Vir Biotechnology (VIR)
Nasdaq • VIR • US92764N1028
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 11.2% of free float sold short, 7.6 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
Market Cap
2.09b USD | # 3808 in US
Volume
1.95m shares | 20.87m USD
Shares Outstanding
169.22m
Free Float Shares
76.66% | 129.72m
